Open Access
Table 1
Results of recombinant antigen-based immunochromatography tests (NIE, SsIR, and NIE-SsIR ICT kits) for detection of anti-Strongyloides IgG antibody in human serum samples.
Conditions represented by sera | No. of sera tested | NIE ICT kit |
SsIR ICT kit |
NIE-SsIR ICT kit |
---|---|---|---|---|
No. positive2 | No. positive2 | No. positive2 | ||
Group I | ||||
Healthy controls | 40 | 0 | 0 | 0 |
Group II | ||||
Proven strongyloidiasis | 100 | 81 | 89 | 95 |
Group III | ||||
Giardiasis | 7 | 1 | 2 | 2 |
Amoebiasis | 10 | 1 | 3 | 0 |
Blastocystosis | 10 | 2 | 4 | 3 |
Opisthorchiasis | 10 | 5 | 2 | 0 |
Fascioliasis | 10 | 3 | 1 | 3 |
Paragonimiasis | 10 | 2 | 1 | 0 |
Taeniasis | 10 | 2 | 3 | 1 |
Cysticercosis | 10 | 3 | 2 | 2 |
Sparganosis | 7 | 3 | 2 | 3 |
Hookworm infections | 10 | 4 | 4 | 1 |
Ascariasis | 10 | 0 | 0 | 0 |
Trichuriasis | 10 | 2 | 0 | 0 |
Trichinellosis | 10 | 0 | 2 | 1 |
Angiostrongyliasis | 10 | 1 | 3 | 2 |
Gnathostomiasis | 10 | 0 | 2 | 0 |
Capillariasis | 10 | 2 | 1 | 1 |
Diagnostic values [95% CI1] | ||||
Sensitivity (%) | 81.0 [71.9–88.2] | 89.0 [81.2–94.4] | 95.0 [88.7–98.4] | |
Specificity (%) | 84.0 [78.1–88.9] | 83.5 [77.5–88.4] | 90.2 [85.1–94.0] | |
Positive likelihood ratio | 5.07 [3.62–7.10] | 5.40 [3.90–7.46] | 9.70 [6.31–14.90] | |
Negative likelihood ratio | 0.23 [0.15–0.34] | 0.13 [0.08–0.23] | 0.06 [0.02–0.13] |
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.